Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain

被引：0

作者：

Johnson, R. ^{[1
]}

Warren, R. M. ^{[1
]}

van der Spuy, G. D. ^{[1
]}

Gey van Pittius, N. C. ^{[1
]}

Theron, D. ^{[2
]}

Streicher, E. M. ^{[1
]}

Bosman, M. ^{[3
]}

Coetzee, G. J. ^{[3
]}

van Helden, P. D. ^{[1
]}

Victor, T. C. ^{[1
]}

机构：

[1] Univ Stellenbosch, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol,Dept Biomed Sci, DST,NRF Ctr Excellence Biomed TB Res,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa

[2] Brewelskloof Hosp, MDR Unit, Worcester, MA USA

[3] Natl Hlth Lab Serv, Cape Town, South Africa

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2010年 / 14卷 / 01期

基金：

新加坡国家研究基金会;

关键词：

drug resistance; Mycobacterium tuberculosis; Beijing genotype; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Temporal analysis of drug-resistant tuberculosis (TB) cases in the Western Cape, South Africa, showed a 1.5-fold increase over a 2-year period, suggesting a doubling time of 8.2 years. This increase was strongly associated with multidrug resistance and the Beijing genotype. Forty-two per cent of the overall increase was due to the Beijing genotype strain R220, suggesting that this strain had evolved unique properties that allowed for both acquisition and transmission of drug resistance. To curb the drug-resistant TB epidemic in this setting, it will be essential to implement rapid diagnostics and efficient infection control measures, improve contact screening and ensure treatment adherence.

引用

页码：119 / 121

页数：3

共 50 条

[21] Drug-resistant tuberculosis in the WHO Western Pacific Region
Islam, Tauhid
Hiatt, Tom
Hennig, Cornelia
Nishikiori, Nobuyuki
WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2014, 5 (04) : 34 - 46
[22] Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
Husain, Aliabbas A.
Kupz, Andreas
Kashyap, Rajpal S.
EPIDEMIOLOGY AND HEALTH, 2021, 43
[23] Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012
Leuow, K.
Papaventsis, D.
Kourkoundi, S.
Ioannidis, P.
Karabela, S.
Tsikrika, S.
Marinou, I.
Papavasileiou, A.
Stone, M.
Drobniewski, F.
Paparisos, V.
Vogiatzakis, E.
EUROSURVEILLANCE, 2013, 18 (12): : 4 - 7
[24] Drug-resistant tuberculosis
Nations, Joel Anthony
Lazarus, Angeline A.
Walsh, Thomas E.
DM DISEASE-A-MONTH, 2006, 52 (11-12): : 435 - 440
[25] DRUG-RESISTANT TUBERCULOSIS
不详
BRITISH MEDICAL JOURNAL, 1981, 283 (6287): : 336 - 337
[26] DRUG-RESISTANT TUBERCULOSIS
HANNA, BA
BONK, S
TICK, LK
LANCET, 1993, 342 (8885): : 1496 - 1496
[27] DRUG-RESISTANT TUBERCULOSIS
DUERDEN, BI
BRITISH MEDICAL JOURNAL, 1995, 310 (6984): : 940 - 940
[28] DRUG-RESISTANT TUBERCULOSIS
SNIDER, DE
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03): : 732 - 732
[29] DRUG-RESISTANT TUBERCULOSIS
BASS, JB
KIRKPATRICK, MB
SEMINARS IN RESPIRATORY MEDICINE, 1988, 9 (05): : 470 - 473
[30] Drug-resistant tuberculosis
Davies, PDO
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2001, 94 (06) : 261 - 263

← 1 2 3 4 5 →